Press Release

Asthma Warning Sensors Market is expected to grow at a CAGR of 9.74% through 2031

The involvement of technology in the healthcare industry is driving growth in the Global Asthma Warning Sensors Market over the forecast period, 2027-2031.

According to TechSci Research report, Asthma Warning Sensors Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2027-2031, The Global Asthma Warning Sensors Market will grow from USD 12.55 Billion in 2025 to USD 21.92 Billion by 2031 at a 9.74% CAGR, with an impressive CAGR on the account of rapidly increasing pollution in the whole world. Changes in the climatic conditions is also driving the growth of the global asthma warning sensors market in the upcoming five years.

Rapidly evolving technologies and consistent research is also aiding the growth of the global asthma warning sensors market in the next five years. Moreover, the advancement of the healthcare sector and the development of smart inhalers, smart medical sensors, and AI-enabled asthma warning sensors are expected to drive growth in the global asthma warning sensors market over the next five years. Furthermore, the increasing penetration of smart technologies, internet-enabled services, the Internet of Things, and artificial intelligence is further substantiating the growth of the global asthma warning sensors market in the forecast period, until 2027.

Bronchial allergies are a lifestyle-wide, continuous disease that affects the breathing pattern of the patients. Provision of medical sensors like asthma warning sensors aids the demand for a medical sensing device monitoring the condition of patient suffering from asthma and related breathing issues.

Asthma warning sensors are a type of connected inhaler that use various technologies, such as Bluetooth sensors, attached to detect medication use and share data with physicians, may promote adherence to recommended controller medications, and proactively detect worsening asthma symptoms.

These devices specifically measure the pollutants that can set-off asthma attacks and warn people with asthma for probable attacks or worsening breathing conditions. In September 2020, Teva Pharmaceutical Industries Ltd launched two digital inhalers, AirDuo® Digihaler® (fluticasone propionate and salmeterol) and ArmonAir® Digihaler® (fluticasone propionate), to enable patients to share objective inhaler-use data with their healthcare providers.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Asthma warning sensors Market"

https://www.techsciresearch.com/report/asthma-warning-sensors-market/9317.html

The global asthma warning sensors market is segmented by type, technology, measured parameter, end user, competitive landscape, and region. By technology, the market is further bifurcated into AI, IoT, machine learning, and other categories. Artificial intelligence is expected to account for the largest share of the market and dominate the medical device segment, owing to advances in technology and their penetration into medical device development.

Artificial intelligence (AI) in asthma warning sensors is responsible for consistent and monitored delivery of the drugs directly to the respiratory tract of patients so as to increase the efficacy of drug delivery and maintain track record. Moreover, leading manufacturers of smart asthma warning sensors are collaborating with digital and software companies to serve the target population.

Internet of Things (IoT) are also anticipated to register esteemed growth in the next five years on the account of increased penetration of internet and its services in the medical devices. Furthermore, demand for the services like automatic retraction of collected data is further aiding the growth of the global asthma warning sensors market in the future five years.

Major market players leading the global asthma warning sensors market include:

  • Philips Healthcare
  • ResMed Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Propeller Health
  • Adherium Limited
  • Cohero Health, Inc.


Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=9317

Customers can also request for 10% free customization on this report.


“North America is anticipated to dominate the regional segment analysis of the market growth. The booming healthcare industry in the countries like United States and Canada are major reasons behind the impressive growth of the market. Moreover, increasing pollution is causing more severe conditions of asthma among the population thereby surging the demands for the asthma warning sensors and aiding the growth of the global asthma warning sensors market. New market players are advised to focus their resources on extended research and development of the technologically advanced products that would aid their brand establishment as well as support their future growth in the upcoming five years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

Asthma Warning Sensors Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type (Wearable v/s Non-Wearable), By Technology (AI, IoT, Machine Learning, Others), By Parameter Measured (FEV1 v/s Peak Flow), By End User (Hospitals & Clinics v/s Homecare), By Region 2021-2031F”, has evaluated the future growth potential of global Asthma warning sensors and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global asthma warning sensors market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

Relevant News